A more recent addition to the urologist's toolbox is the prostate cancer antigen 3, PCA3, identified by Bussemaker and colleagues in 1999 [14] under the name DD3 using digital display screening for prostate cancer-specific RNAs (for a recent review see [15]). This evidence concerns the gene PCA3 and prostate carcinoma.